Cleared Traditional

K912365 - TDX(R)/TDXFLX(TM) & ADX(R) PROPOXPHENE ASSAYS (FDA 510(k) Clearance)

Aug 1991
Decision
79d
Days
Class 2
Risk

K912365 is an FDA 510(k) clearance for the TDX(R)/TDXFLX(TM) & ADX(R) PROPOXPHENE ASSAYS. This device is classified as a Enzyme Immunoassay, Propoxyphene (Class II - Special Controls, product code JXN).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on August 16, 1991, 79 days after receiving the submission on May 29, 1991.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3700.

Submission Details

510(k) Number K912365 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 29, 1991
Decision Date August 16, 1991
Days to Decision 79 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code JXN — Enzyme Immunoassay, Propoxyphene
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3700